NCT02858258 2017-12-19ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell LymphomaEuropean Mantle Cell Lymphoma NetworkPhase 3 Recruiting870 enrolled